Listed
Stock Code: 183490
| Company Name | (주)엔지켐생명과학 |
| English Name | ENZYCHEM LIFESCIENCES CORPORATION |
| Business Reg. No. | 3148127038 |
| CEO | 손기영 |
| Address | 충청북도 제천시 바이오밸리로 59 |
| Industry | 기초 의약 물질 제조업 |
| Industry Code | 211 |
| Established | 19990720 |
| Phone | 043-652-2845 |
| Website | www.enzychem.co.kr |
| Regular Employees | 130persons |
| Corp. Reg. No. | 1601110084890 |
Venture Certified
| 연구개발기업 | 2000-05-29 ~ 2002-05-28 | 20001522710601 | 2000-05-29 |
| 신기술기업(고도기술수반산업) | 2002-11-15 ~ 2004-11-14 | 20021522211498 | 2000-05-29 |
| 신기술기업(고도기술수반산업) | 2004-11-29 ~ 2006-11-14 | 041522032400228 | 2000-05-29 |
| 연구개발유형 | 2006-11-15 ~ 2008-11-14 | 20060100369 | 2000-05-29 |
| 벤처투자유형 | 2011-07-07 ~ 2013-07-06 | 20110300133 | 2000-05-29 |
| 벤처투자유형 | 2013-07-07 ~ 2015-07-06 | 20130300179 | 2000-05-29 |
| 벤처투자유형 | 2015-07-07 ~ 2017-07-06 | 20150300245 | 2000-05-29 |
| 연구개발유형 | 2017-07-07 ~ 2019-07-06 | 20170107256 | 2000-05-29 |
| 연구개발유형 | 2019-07-07 ~ 2021-07-06 | 20190108425 | 2000-05-29 |
| 연구개발유형 | 2021-07-07 ~ 2024-07-06 | 20210729020060 | 2000-05-29 |
| 연구개발유형 | 2024-07-07 ~ 2027-07-06 | 20240702020008 | 2000-05-29 |
Revenue CAGR +49.9%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 774B | 760B | 266B | 230B |
| Operating Profit | -132B | -144B | -147B | -208B |
| Net Profit | -221B | -94B | -251B | -279B |
| Total Assets | 1,817B | 2,115B | 2,476B | 1,331B |
| Total Liabilities | 203B | 169B | 458B | 584B |
| Total Equity | 1,615B | 1,946B | 2,017B | 747B |
Operating Loss: Op. profit -132B
4 Consecutive Years of Net Loss
Debt Ratio Surge (+4pp YoY)
▲ 84.7%
▲ 20.5%
▲ 68.9%
▼ 65.7%
▲ 24.8%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 손기영 | 사내이사 | 경영총괄 | - |
| 정재한 | 미등기 | 경영 지원 | - |
| 강병규 | 미등기 | 생산 | - |
| 김소빈 | 미등기 | 글로벌 신약개발 | - |
| 김혜경 | 사내이사 | 경영 본부장 | - |
| 강인수 | 사내이사 | 혁신성장 본부장 | - |
| 오혜영 | 사외이사 | 자문 | - |
| 임형빈 | 감사 | 감사 | - |
| 정현철 | 미등기 | 의약품 사업 본부장 | - |
| 최광식 | 미등기 | 품질 관리 | - |
| 심성보 | 미등기 | 의약품 연구소장 | - |
| 최재호 | 미등기 | 영업 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 59persons |
| CEO | 손기영 |
| Est. Avg. Annual Salary | 4,98210K (41510K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -2persons |
| Net Change (12 mo) | -2persons |
| NPS Join Date | 1999-09-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "충청북도 제천시 바이오밸리로",
"brno": "314812****",
"cappedWarning": false,
"companyName": "(주)엔지켐생명과학",
"estimatedAvgAnnualSalary": 49818180,
"estimatedAvgMonthlySalary": 4151515,
"fetchedAt": "2026-03-05T19:19:56.568Z",
"industryCode": "514990",
"industryName": "그 외 기타 상품 전문 도매업",
"joinDate": "19990901",
"last12MonthsHired": 0,
"last12MonthsLeft": 2,
"last12MonthsNetChange": -2,
"leaveDate": null,
"monthlyPensionAmount": 23269240,
"monthlyTrend": [
{
"lostSubscribers": 2,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6678998",
"status": "1",
"styleCode": "1",
"subscriberCount": 59,
"turnoverMonths": 1
}{
"address": "충북 제천시",
"ceo_name": "손기영",
"certificate": [
{
"cert_number": "20001522710601",
"changes": "",
"disclosure_date": "2000-05-29",
"first_cert_date": "2000-05-29",
"no": "1",
"type": "연구개발기업",
"valid_period": "2000-05-29 ~ 2002-05-28"
},
{
"cert_number": "20021522211498",
"changes": "",
"disclosure_date": "2002-11-15",
"first_cert_date": "2000-05-29",
"no": "2",
"type": "신기술기업(고도기술수반산업)",
"valid_period": "2002-11-15 ~ 2004-11-14"
},
{
"cert_number": "041522032400228",
"changes": "",
"disclosure_date": "2004-11-29",
"first_cert_date": "2000-05-29",
"no": "3",
"type": "신기술기업(고도기술수반산업)",
"valid_period": "2004-11-29 ~ 2006-11-14"
},
{
"cert_number": "20060100369",
"changes": "",
"disclosure_date": "2006-11-02",
"first_cert_date": "2000-05-29",
"no": "4",
"type": "연구개발유형",
"valid_period": "2006-11-15 ~ 2008-11-14"
},
{
"cert_number": "20110300133",
"changes": "",
"disclosure_date": "2011-07-07",
"first_cert_date": "2000-05-29",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2011-07-07 ~ 2013-07-06"
},
{
"cert_number": "20130300179",
"changes": "",
"disclosure_date": "2013-07-18",
"first_cert_date": "2000-05-29",
"no": "6",
"type": "벤처투자유형",
"valid_period": "2013-07-07 ~ 2015-07-06"
},
{
"cert_number": "20150300245",
"changes": "",
"disclosure_date": "2015-06-25",
"first_cert_date": "2000-05-29",
"no": "7",
"type": "벤처투자유형",
"valid_period": "2015-07-07 ~ 2017-07-06"
},
{
"cert_number": "20170107256",
"changes": "",
"disclosure_date": "2017-06-22",
"first_cert_date": "2000-05-29",
"no": "8",
"type": "연구개발유형",
"valid_period": "2017-07-07 ~ 2019-07-06"
},
{
"cert_number": "20190108425",
"changes": "",
"disclosure_date": "2019-07-19",
"first_cert_date": "2000-05-29",
"no": "9",
"type": "연구개발유형",
"valid_period": "2019-07-07 ~ 2021-07-06"
},
{
"cert_number": "20210729020060",
"changes": "",
"disclosure_date": "2021-07-29",
"first_cert_date": "2000-05-29",
"no": "10",
"type": "연구개발유형",
"valid_period": "2021-07-07 ~ 2024-07-06"
},
{
"cert_number": "20240702020008",
"changes": "",
"disclosure_date": "2024-07-02",
"first_cert_date": "2000-05-29",
"no": "11",
"type": "연구개발유형",
"valid_period": "2024-07-07 ~ 2027-07-06"
}
],
"company_name": "(주)엔지켐생명과학",
"financials": {
"2022": {
"capital_stock": 42413781000,
"cost_of_sales": 24221315000,
"current_assets": 219238512000,
"current_liabilities": 42188783000,
"gross_profit": 2416316000,
"net_income": -25419445000,
"net_income_bs": -24918899000,
"non_current_assets": 27599042000,
"non_current_liabilities": 3213022000,
"non_operating_expenses": 15122854000,
"non_operating_income": 4202211000,
"operating_profit": -14498802000,
"revenue": 26637631000,
"sga_expenses": 16915118000,
"total_assets": 246837553000,
"total_equity": 201435749000,
"total_liabilities": 45401805000
},
"2023": {
"capital_stock": 42532781000,
"cost_of_sales": 31514528000,
"current_assets": 168443075000,
"current_liabilities": 11072933000,
"gross_profit": 3597432000,
"net_income": -9068827000,
"net_income_bs": -8781125000,
"non_current_assets": 36815041000,
"non_current_liabilities": 405278000,
"non_operating_expenses": 734727000,
"non_operating_income": 5614156000,
"operating_profit": -13948256000,
"revenue": 35111961000,
"sga_expenses": 17545688000,
"total_assets": 205258117000,
"total_equity": 193779905000,
"total_liabilities": 11478211000
}
},
"industry": "기초 의약 물질 제조업",
"investment": [
{
"amount": "1,183,806,000",
"changes": "1,183,806,000",
"date": "2012-11-02"
}
],
"phone": "02-501-****",
"source": "pg_migration"
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| Venture System Detail | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |